Phenotypes associated with this allele

• Allele Symbol: Slc38a10^{tm2a(EUCOMM)Wtsi}
• Allele Name: targeted mutation 2a, Wellcome Trust Sanger Institute
• Allele ID: MGI:4441779
• Summary: 1 genotype

Jump to	Allelic Composition	Genetic Background	Genotype ID
hm1	Slc38a10^tm2a(EUCOMM)Wtsi/Slc38a10^tm2a(EUCOMM)Wtsi	C57BL/6N-Slc38a10^tm2a(EUCOMM)Wtsi/H	MGI:5782192

Genotype
MGI:5782192

hm1

• Allelic Composition: Slc38a10^{tm2a(EUCOMM)Wtsi}/Slc38a10^{tm2a(EUCOMM)Wtsi}
• Genetic Background: C57BL/6N-Slc38a10^{tm2a(EUCOMM)Wtsi}/H
• Cell Lines: EPD0023_1_F07

Data Sources

IMPC Data for Slc38a10

• ♀: phenotype observed in females
• ♂: phenotype observed in males
• N: normal phenotype

behavior/neurological

abnormal response to tactile stimuli ( J:165965 )

♂

IMPC - ICS

growth/size/body

decreased lean body mass ( J:165965 )

IMPC - HAR

decreased body weight ( J:165965 )

IMPC - HAR

hematopoietic system

decreased erythrocyte cell number ( J:165965 )

IMPC - ICS

decreased hemoglobin content ( J:165965 )

IMPC - HAR

increased mean corpuscular hemoglobin concentration ( J:165965 )

IMPC - ICS

thrombocytopenia ( J:165965 )

IMPC - HAR

homeostasis/metabolism

increased circulating triglyceride level ( J:165965 )

♀

IMPC - ICS

decreased circulating calcium level ( J:165965 )

IMPC - ICS

increased circulating potassium level ( J:165965 )

♀

IMPC - ICS

decreased circulating sodium level ( J:165965 )

IMPC - ICS

decreased circulating alkaline phosphatase level ( J:165965 )

IMPC - HAR

decreased circulating amylase level ( J:165965 )

IMPC - ICS

decreased circulating serum albumin level ( J:165965 )

IMPC - HAR

decreased circulating total protein level ( J:165965 )

IMPC - ICS

skeleton

decreased bone mineral density ( J:165965 )

IMPC - HAR

abnormal bone mineralization ( J:165965 )

IMPC - HAR

vision/eye

abnormal eye morphology ( J:165965 )

♂

IMPC - ICS

abnormal retina morphology ( J:165965 )

♂

IMPC - ICS